Plasma titers of antibodies against Epstein-Barr virus BZLF1 and risk of multiple sclerosis

Neuroepidemiology

Volumn 28, Issue 4, 2007, Pages 214-215

  Massa, J ^a   Munger, K L ^a   O'Reilly, E J ^a   Falk, K I ^c   Ascherio, A ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Swedish Institute for Communicable Infectious Disease Control   (Sweden)

Author keywords

Anti BZLF1 antibodies; Epstein Barr virus; Multiple sclerosis

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMEDIATE EARLY PROTEIN BZLF1; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY TITER; ARTICLE; CANCER RISK; CASE CONTROL STUDY; DIAGNOSTIC VALUE; EPSTEIN BARR VIRUS; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NASOPHARYNX CARCINOMA; RISK ASSESSMENT;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; COHORT STUDIES; DNA-BINDING PROTEINS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 35348852217     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108113     Document Type: Article

References (6)

1. Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ, Hankinson SE, Hunter DJ: Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001;286:3083-3088.
2. Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nystrom L, Dillner J, Forsgren L: An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004;62:2277-2282.
3. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A: Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005;293:2496-2500.
4. Delorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A: Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 2006;63:839-844.
5. Cochet C, Martel-Renoir D, Grunewald V, Bosq J, Cochet G, Schwaab G, Bernaudin JF, Joab I: Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 1993;197:358-365.
6. Lunemann JD, Edwards N, Muraro PA, Hayashi S, Cohen JI, Munz C, Martin R: Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006;129:1493-1506.